Healthcare provider profile · identity verified

Rafael Torres Velez, M.D.

Obstetrics & Gynecology · CAROLINA, PR · NPI 1720084874

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	336	80
Metoprolol Succinate	Metoprolol Succinate	208	42
Metformin Hcl	Metformin Hcl	192	31
Losartan Potassium	Losartan Potassium	170	42
Methylprednisolone	Methylprednisolone	140	87
Atorvastatin Calcium	Atorvastatin Calcium	133	34
Omeprazole	Omeprazole	132	42
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	124	72
Synthroid	Levothyroxine Sodium	120	23
Tamsulosin Hcl	Tamsulosin Hcl	113	32
Clonazepam	Clonazepam	106	30
Simvastatin	Simvastatin	93	20
Levothyroxine Sodium	Levothyroxine Sodium	87	17
Glimepiride	Glimepiride	85	16
Ozempic	Semaglutide	82	19
Amlodipine Besylate	Amlodipine Besylate	80	27
Azithromycin	Azithromycin	80	67
Alprazolam	Alprazolam	79	18
Moxifloxacin Hcl	Moxifloxacin Hcl	78	66
Tramadol Hcl	Tramadol Hcl	75	19
Lisinopril	Lisinopril	73	14
Nabumetone	Nabumetone	72	36
Albuterol Sulfate	Albuterol Sulfate	71	45
Furosemide	Furosemide	69	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	16
Temazepam	Temazepam	69	14
Hydrochlorothiazide	Hydrochlorothiazide	64	30
Meloxicam	Meloxicam	64	29
Atenolol	Atenolol	61	12
Montelukast Sodium	Montelukast Sodium	61	22
Tizanidine Hcl	Tizanidine Hcl	61	32
Famotidine	Famotidine	59	16
Carvedilol	Carvedilol	58	14
Zolpidem Tartrate	Zolpidem Tartrate	56	12
Mometasone Furoate	Mometasone Furoate	54	33
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	54	42
Clopidogrel	Clopidogrel Bisulfate	49	12
Rosuvastatin Calcium	Rosuvastatin Calcium	49	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	43
Dicyclomine Hcl	Dicyclomine Hcl	48	25
Levofloxacin	Levofloxacin	48	43
Pantoprazole Sodium	Pantoprazole Sodium	45	19
Diclofenac Potassium	Diclofenac Potassium	42	28
Dexamethasone	Dexamethasone	41	32
Fluconazole	Fluconazole	38	33
Janumet	Sitagliptin Phos/Metformin Hcl	38	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Metronidazole	Metronidazole	37	33
Mupirocin	Mupirocin	37	30
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	15
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Meclizine Hcl	Meclizine Hcl	34	18
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	32	11
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Estazolam	Estazolam	31	suppressed
Irbesartan	Irbesartan	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	22
Ketoconazole	Ketoconazole	30	14
Naproxen Sodium	Naproxen Sodium	30	14
Pentoxifylline	Pentoxifylline	30	suppressed
Ramipril	Ramipril	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	11
Albuterol Sulfate Hfa	Albuterol Sulfate	28	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	20
Finasteride	Finasteride	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Clindamycin Hcl	Clindamycin Hcl	25	20
Lorazepam	Lorazepam	25	suppressed
Prednisone	Prednisone	25	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	25	13
Diclofenac Sodium Er	Diclofenac Sodium	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Progesterone	Progesterone, Micronized	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	16
Lansoprazole	Lansoprazole	22	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Acyclovir	Acyclovir	20	11
Ketorolac Tromethamine	Ketorolac Tromethamine	18	11
Terconazole	Terconazole	18	16
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Cephalexin	Cephalexin	16	12
Eliquis	Apixaban	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Allopurinol	Allopurinol	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Sertraline Hcl	Sertraline Hcl	14	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	14	12
Baclofen	Baclofen	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	11
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Diazepam	Diazepam	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	13	13
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Celecoxib	Celecoxib	12	11
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Glipizide	Glipizide	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Procto-Med Hc	Hydrocortisone	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Cilostazol	Cilostazol	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Trazodone Hcl	Trazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error